Analysed Monte Rosa Therapeutics Inc (GLUE:NASDAQ) News Sources
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant ...
Yahoo Finance
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant ...
Markets Insider
What is the current price of Monte Rosa Therapeutics Inc (GLUE:NASDAQ)?
The current price of Monte Rosa Therapeutics Inc (GLUE:NASDAQ) is $18.5.
Monte Rosa Therapeutics Inc (GLUE:NASDAQ) absolute price change since previous trading day?
The absolute price change of Monte Rosa Therapeutics Inc (GLUE:NASDAQ) since the previous trading day is $0.41.
Monte Rosa Therapeutics Inc (GLUE:NASDAQ) percentage price change since previous trading day?
The percentage price change of Monte Rosa Therapeutics Inc (GLUE:NASDAQ) since the previous trading day is 2.27%.
What is This Week's average sentiment score for Monte Rosa Therapeutics Inc (GLUE:NASDAQ)?
This Week's average sentiment score for Monte Rosa Therapeutics Inc (GLUE:NASDAQ) is 91 out of 100.
What is This Week's average sentiment for Monte Rosa Therapeutics Inc (GLUE:NASDAQ)?
This Week's sentiment for Monte Rosa Therapeutics Inc (GLUE:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.